Anaplastic Astrocytomas

1
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
1
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Nektar Therapeutics
Nektar TherapeuticsSAN FRANCISCO, CA
1 program
1
Etirinotecan pegolPhase 21 trial
Active Trials
NCT01663012CompletedEst. Feb 2015

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Nektar TherapeuticsEtirinotecan pegol

Clinical Trials (1)

NCT01663012Nektar TherapeuticsEtirinotecan pegol

Phase II NKTR-102 In Bevacizumab-Resistant High Grade Glioma

Start: Jul 2012Est. completion: Feb 2015
Phase 2Completed

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 companies competing in this space